Comparing pregnancy, childbirth, and neonatal outcomes in women with different phenotypes of polycystic ovary syndrome and healthy women: a prospective cohort study

References

• Azziz R. Androgen excess is the key element in polycystic ovary syndrome. Fertil Steril. 2003;80:252–254.
   PubMed Web of Science ®Google Scholar
• Knochenhauer ES, Key TJ, Kahsar-Miller M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078–3082.
   PubMed Web of Science ®Google Scholar
• Asuncion M, Calvo RM, San Millan JL, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–2438.
   PubMed Web of Science ®Google Scholar
• Michelmore KF, Balen AH, Dunger DB, et al. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol. 1999;51:779–786.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999;84:4006–4011.
   PubMed Web of Science ®Google Scholar
• Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome. Lancet. 2007;370:685–697.
   PubMed Web of Science ®Google Scholar
• Wortsman J, de Angeles S, Futterweit W, et al. Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome. J Reprod Med. 1991;36:659–661.
   PubMed Web of Science ®Google Scholar
• Haakova L, Cibula D, Rezabek K, et al. Pregnancy outcome in women with PCOS and in controls matched by age and weight. Hum Reprod. 2003;18:1438–1441.
   PubMed Web of Science ®Google Scholar
• Bjercke S, Dale PO, Tanbo T, et al. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest. 2002;54:94–98.
   PubMed Web of Science ®Google Scholar
• Verberg MF, Gillott DJ, Al-Fardan N, et al. Hyperemesis gravidarum, a literature review. Hum Reprod Update. 2005;11:527–539.
   PubMed Web of Science ®Google Scholar
• Orio F, Jr., Palomba S, Cascella T, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:2–5.
   PubMed Web of Science ®Google Scholar
• Sugiura-Ogasawara M, Sato T, Suzumori N, et al. The polycystic ovary syndrome does not predict further miscarriage in Japanese couples experiencing recurrent miscarriages. Am J Reprod Immunol. 2009;61:62–67.
   PubMed Web of Science ®Google Scholar
• Carlsen SM, Vanky E. Metformin influence on hormone levels at birth, in PCOS mothers and their newborns. Hum Reprod. 2010;25:786–790.
   PubMed Web of Science ®Google Scholar
• Palomba S, Falbo A, Russo T, et al. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril. 2010;94:1805–1811.
   PubMed Web of Science ®Google Scholar
• Qin JZ, Pang LH, Li MJ, et al. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2013;11:56.
   PubMed Web of Science ®Google Scholar
• Baweja R, Bhattacharya SK, Choudhury SD, et al. Indian Council of Medical Research. Task Force on Hormonal Contraception: phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive. Contraception. 1985;32:383–394.
   PubMed Web of Science ®Google Scholar
• Ferrimanm D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–1447.
   PubMed Web of Science ®Google Scholar
• Bazarganipour F, Ziaei S, Montazeri A, et al. Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach. Fertil Steril. 2013;100:1389–1396.
   PubMed Web of Science ®Google Scholar
• Lever WF, Schaumburg-Lever G. Acne vulgaris. Histopatbology of the skin. 7th ed. Philadelphia: JB Lippincott. 1990.
   Google Scholar
• Owen J, Szychowski JM, Hankins G, et al. Does mid-trimester cervical length ≥ 25 mm predict preterm birth in high-risk women? Am J Obstet Gynecol. 2010;203:393.e1–393.e5.
   PubMed Web of Science ®Google Scholar
• Koren G, Boskovic R, Hard M, et al. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2002;186:S228–S231.
   PubMed Web of Science ®Google Scholar
• Roos N, Kieler H, Sahlin L, et al. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. Bmj. 2011;13:343.
   Google Scholar
• Veltman-Verhulst SM, van Haeften TW, Eijkemans MJ, et al. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome. Hum Reprod. 2010;25:3123–3128.
   PubMed Web of Science ®Google Scholar
• Vankrieken L. Testosterone and the free androgen index. Los Angeles, CA: Diagnostic Products Corporation; 1997.
   Google Scholar
• Svendsen PF, Madsbad S, Nilas L. The insulin-resistant phenotype of polycystic ovary syndrome. Fertil Steril. 2010;94:1052–1058.
   PubMed Web of Science ®Google Scholar
• Shroff R, Syrop CH, Davis W, et al. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril. 2007;88:1389–1395.
   PubMed Web of Science ®Google Scholar
• Chang WY, Knochenhauer ES, Bartolucci AA, et al. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril. 2005;83:1717–1723.
   PubMed Web of Science ®Google Scholar